Abstract
Get full access to this article
View all access options for this article.
References
1.
Blombery
P
Scully
M.
Management of thrombotic thrombocytopenic purpura: current perspectives . J Blood Med . 2014 ;5 :15 -23 . doi:10.2147/JBM.S46458
2.
Shaz
B
Dunbar
N
. Indications for therapeutic plasma exchange in thrombotic microangiopathies . http://www.hematology.org/Thehematologist/Ask/6798.aspx#. Accessed February 12, 2019 .
3.
Furlan
M
Lämmle
B.
Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura—new insights into underlying biochemical mechanisms . Nephrol Dial Transplant . 2000 ;15 :1112 -1114 . doi:10.1093/ndt/15.8.1112
4.
George
JN
Cuker
A
. Acquired TTP: clinical manifesta-tions and diagnosis . https://www.uptodate.com/contents/acquired-ttp-clinical-manifestations-and-diagnosis#H1145369. Accessed February 12, 2019 .
5.
Loirat
C
Veyradier
A
Girma
JP
Ribba
AS
Meyer
D.
Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children . Semin Thromb Hemost . 2006 ;32 :90 -97 .
6.
Russell
JE
. Anemia; low hemoglobin, low hematocrit, low red cell count . https://www.cancertherapyadvisor.com/critical-care-medicine/anemia-low-hemoglobin-low-hematocrit-low-red-cell-count/article/584976/. Accessed February 18, 2019 .
7.
Wun
T.
Thrombotic thrombocytopenic purpura (TTP) follow-up . https://emedicine.medscape.com/article/206598-followup. Published February 18, 2019. Accessed February 11, 2019 .
8.National Heart, Lung, and Blood Institute . Thrombotic thrombocytopenic purpura . https://www.nhlbi.nih.gov/health-topics/thrombotic-thrombocytopenic-purpura. Accessed February 18, 2019 .
9.
Page
EE
Hovinga
JAK
Terrell
DR
Vesely
SK
George
JN.
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura . Blood . 2016 ;127 :3092 -3094 .
10.
Orkin
SH
Nathan
DG
Ginsburg
D
Look
T
Fisher
DE
Lux
S.
Nathan and Oski’s Hematology of Infancy and Childhood . Vol 2 . 8th ed. Philadelphia, PA : Saunders ; 2003 .